For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.
CureVac turns up the heat in ongoing patent litigation with Pfizer – Pharmaceutical Technology
In July 2022, CureVac filed a patent infringement lawsuit against BioNTech and two of its subsidiaries regarding Comirnaty, seeking compensation. Image Credit: Freedomz / Shutterstock.